Konstantinos E Farsalinos1, Kurt A Kistler2, Gene Gillman3, Vassilis Voudris4. 1. Department of Cardiology, Onassis Cardiac Surgery Center, Kallithea, Greece; kfarsalinos@gmail.com. 2. Department of Chemistry, Pennsylvania State University Brandywine, Media, PA; 3. Enthalpy Analytical, Inc, Durham, NC. 4. Department of Cardiology, Onassis Cardiac Surgery Center, Kallithea, Greece;
Abstract
INTRODUCTION: The purpose of this study was to evaluate sweet-flavored electronic cigarette (EC) liquids for the presence of diacetyl (DA) and acetyl propionyl (AP), which are chemicals approved for food use but are associated with respiratory disease when inhaled. METHODS: In total, 159 samples were purchased from 36 manufacturers and retailers in 7 countries. Additionally, 3 liquids were prepared by dissolving a concentrated flavor sample of known DA and AP levels at 5%, 10%, and 20% concentration in a mixture of propylene glycol and glycerol. Aerosol produced by an EC was analyzed to determine the concentration of DA and AP. RESULTS: DA and AP were found in 74.2% of the samples, with more samples containing DA. Similar concentrations were found in liquid and aerosol for both chemicals. The median daily exposure levels were 56 μg/day (IQR: 26-278 μg/day) for DA and 91 μg/day (IQR: 20-432 μg/day) for AP. They were slightly lower than the strict NIOSH-defined safety limits for occupational exposure and 100 and 10 times lower compared with smoking respectively; however, 47.3% of DA and 41.5% of AP-containing samples exposed consumers to levels higher than the safety limits. CONCLUSIONS: DA and AP were found in a large proportion of sweet-flavored EC liquids, with many of them exposing users to higher than safety levels. Their presence in EC liquids represents an avoidable risk. Proper measures should be taken by EC liquid manufacturers and flavoring suppliers to eliminate these hazards from the products without necessarily limiting the availability of sweet flavors.
INTRODUCTION: The purpose of this study was to evaluate sweet-flavored electronic cigarette (EC) liquids for the presence of diacetyl (DA) and acetyl propionyl (AP), which are chemicals approved for food use but are associated with respiratory disease when inhaled. METHODS: In total, 159 samples were purchased from 36 manufacturers and retailers in 7 countries. Additionally, 3 liquids were prepared by dissolving a concentrated flavor sample of known DA and AP levels at 5%, 10%, and 20% concentration in a mixture of propylene glycol and glycerol. Aerosol produced by an EC was analyzed to determine the concentration of DA and AP. RESULTS:DA and AP were found in 74.2% of the samples, with more samples containing DA. Similar concentrations were found in liquid and aerosol for both chemicals. The median daily exposure levels were 56 μg/day (IQR: 26-278 μg/day) for DA and 91 μg/day (IQR: 20-432 μg/day) for AP. They were slightly lower than the strict NIOSH-defined safety limits for occupational exposure and 100 and 10 times lower compared with smoking respectively; however, 47.3% of DA and 41.5% of AP-containing samples exposed consumers to levels higher than the safety limits. CONCLUSIONS:DA and AP were found in a large proportion of sweet-flavored EC liquids, with many of them exposing users to higher than safety levels. Their presence in EC liquids represents an avoidable risk. Proper measures should be taken by EC liquid manufacturers and flavoring suppliers to eliminate these hazards from the products without necessarily limiting the availability of sweet flavors.
Authors: Thomas J Kim; Barbara L Materna; Janice C Prudhomme; Kathleen B Fedan; Paul L Enright; Nancy M Sahakian; Gayle C Windham; Kathleen Kreiss Journal: Am J Ind Med Date: 2010-09 Impact factor: 2.214
Authors: James M Mathews; Scott L Watson; Rodney W Snyder; Jason P Burgess; Daniel L Morgan Journal: J Agric Food Chem Date: 2010-11-15 Impact factor: 5.279
Authors: Richard Kanwal; Greg Kullman; Chris Piacitelli; Randy Boylstein; Nancy Sahakian; Stephen Martin; Kathleen Fedan; Kathleen Kreiss Journal: J Occup Environ Med Date: 2006-02 Impact factor: 2.162
Authors: Giorgio Romagna; Elena Allifranchini; Elena Bocchietto; Stefano Todeschi; Mara Esposito; Konstantinos E Farsalinos Journal: Inhal Toxicol Date: 2013-05 Impact factor: 2.724
Authors: Jennifer S Pierce; Anders Abelmann; Lauren J Spicer; Rebecca E Adams; Brent L Finley Journal: Crit Rev Toxicol Date: 2014-03-17 Impact factor: 5.635
Authors: Frits G B G J van Rooy; Jos M Rooyackers; Mathias Prokop; Remko Houba; Lidwien A M Smit; Dick J J Heederik Journal: Am J Respir Crit Care Med Date: 2007-05-31 Impact factor: 21.405
Authors: Konstantinos E Farsalinos; Giorgio Romagna; Dimitris Tsiapras; Stamatis Kyrzopoulos; Vassilis Voudris Journal: Int J Environ Res Public Health Date: 2014-04-22 Impact factor: 3.390
Authors: Pebbles Fagan; Pallav Pokhrel; Thaddeus A Herzog; Eric T Moolchan; Kevin D Cassel; Adrian A Franke; Xingnan Li; Ian Pagano; Dennis R Trinidad; Kari-Lyn K Sakuma; Kymberle Sterling; Dorothy Jorgensen; Tania Lynch; Crissy Kawamoto; Mignonne C Guy; Ian Lagua; Sarah Hanes; Linda A Alexander; Mark S Clanton; Camonia Graham-Tutt; Thomas Eissenberg Journal: Nicotine Tob Res Date: 2018-07-09 Impact factor: 4.244
Authors: Gideon St Helen; Delia A Dempsey; Christopher M Havel; Peyton Jacob; Neal L Benowitz Journal: Drug Alcohol Depend Date: 2017-06-30 Impact factor: 4.492
Authors: Michael S Dunbar; Jordan P Davis; Anthony Rodriguez; Joan S Tucker; Rachana Seelam; Elizabeth J D'Amico Journal: Nicotine Tob Res Date: 2019-09-19 Impact factor: 4.244